Drugs / Ad6NSmut
last change Apr 2013 re-read 2 minutes ago

Ad6NSmut

Developed for
hepatitis C virus infection · chronic hepatitis C virus infection
Investigated by
ReiThera Srl · University of Oxford · European Commission

Trials 3 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01701336 Mar → Oct 2012 chronic hepatitis C virus infection ReiThera Srl Completed No outcome recorded
Phase 1 NCT01094873 Nov 2009 → Apr 2013 hepatitis C virus infection ReiThera Srl Completed No outcome recorded
Phase 1 NCT01070407 Jul 2007 → Aug 2010 hepatitis C virus infection ReiThera Srl Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Ad6NSmut ClinicalTrials.gov intervention name — accepted as the source's own label NCT01701336
2

NCT01094873

NCT01070407

Route Intramuscular “by intramuscular route” NCT01094873